"Non alcoholic fatty liver" trang 1 - tải miễn phí từ tailieunhanh
Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: Design and rationale of randomized controlled trial

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: Design and rationale of randomized controlled trial
11    90    4
Associations between nut intake, cognitive function and non‐alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14

Associations between nut intake, cognitive function and non‐alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14
12    17    1
Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease
13    66    0
Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease

Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease
9    64    0
Correlation between hepatic steatosis and liver fibrosis with carotid intima-media thickness and carotid plaques in patients with non-alcoholic liver disease

Correlation between hepatic steatosis and liver fibrosis with carotid intima-media thickness and carotid plaques in patients with non-alcoholic liver disease
9    1    1
Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults
9    62    0
Pediatric non alcoholic fatty liver disease: More on novel treatment targets

Pediatric non alcoholic fatty liver disease: More on novel treatment targets
2    60    0
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017

Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017
10    83    0
Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets

Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets
10    74    0
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: A cross-sectional study using data from KNHANES 2010–2015

Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: A cross-sectional study using data from KNHANES 2010–2015
5    68    0
Is there an association between nonalcoholic fatty liver disease and cognitive function? A systematic review

Is there an association between nonalcoholic fatty liver disease and cognitive function? A systematic review
19    19    1
A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80

A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
10    21    1
Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity

Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity
15    7    1
Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus

Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus
7    94    0
Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
13    108    0
A randomised, double-blind, placebocontrolled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: Implications for treatment of non-alcoholic steatohepatitis

A randomised, double-blind, placebocontrolled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: Implications for treatment of non-alcoholic steatohepatitis
13    54    0
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
13    4    1
Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease
12    85    1
Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice

Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice
9    73    0
Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth

Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth
6    97    0